IPCA LABORATORIES
Back to Cashflow Statement
|
IPCA LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,142 Cr | ₹1,321 Cr | ₹945 Cr | ₹806 Cr | ₹856 Cr |
What is the latest Cash Flow from Operating Activities ratio of IPCA LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,142 Cr |
| Mar2025 | ₹1,321 Cr |
| Mar2024 | ₹945 Cr |
| Mar2023 | ₹806 Cr |
| Mar2022 | ₹856 Cr |
How is Cash Flow from Operating Activities of IPCA LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,142 Cr | -13.57 | |
| Mar2025 | ₹1,321 Cr | 39.87 | |
| Mar2024 | ₹945 Cr | 17.23 | |
| Mar2023 | ₹806 Cr | -5.87 | |
| Mar2022 | ₹856 Cr | - | |
Compare Cash Flow from Operating Activities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,490.5 Cr | 1.5% | 10.7% | 38.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 1.5% |
10.7% |
38.4% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses